Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3427718
Max Phase: Preclinical
Molecular Formula: C51H86N20O11S
Molecular Weight: 1187.44
Molecule Type: Small molecule
Associated Items:
ID: ALA3427718
Max Phase: Preclinical
Molecular Formula: C51H86N20O11S
Molecular Weight: 1187.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C#CCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C51H86N20O11S/c1-4-5-15-40(74)65-32(12-8-24-61-49(55)56)43(77)64-29(2)42(76)66-33(11-6-7-23-52)44(78)67-34(13-9-25-62-50(57)58)45(79)68-35(14-10-26-63-51(59)60)46(80)70-37(22-27-83-3)48(82)69-36(20-21-39(53)73)47(81)71-38(41(54)75)28-30-16-18-31(72)19-17-30/h1,16-19,29,32-38,72H,5-15,20-28,52H2,2-3H3,(H2,53,73)(H2,54,75)(H,64,77)(H,65,74)(H,66,76)(H,67,78)(H,68,79)(H,69,82)(H,70,80)(H,71,81)(H4,55,56,61)(H4,57,58,62)(H4,59,60,63)/t29-,32-,33-,34-,35-,36-,37-,38-/m0/s1
Standard InChI Key: JLPFCINETXKLHJ-YBHWYGJSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1187.44 | Molecular Weight (Monoisotopic): 1186.6506 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ferreira SZ, Carneiro HC, Lara HA, Alves RB, Resende JM, Oliveira HM, Silva LM, Santos DA, Freitas RP.. (2015) Synthesis of a New Peptide-Coumarin Conjugate: A Potential Agent against Cryptococcosis., 6 (3): [PMID:25815145] [10.1021/ml500393q] |
Source(1):